Bayesian Capital Management’s Aterian ATER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,033
Closed -$21K 788
2023
Q1
$21K Buy
+2,033
New +$27.2K ﹤0.01% 729
2022
Q3
Sell
-9,639
Closed -$250K 694
2022
Q2
$250K Buy
9,639
+8,047
+505% +$356K 0.05% 538
2022
Q1
$46K Sell
1,592
-208
-12% -$7.62K 0.01% 734
2021
Q4
$89K Buy
+1,800
New +$133K 0.03% 344

Other funds holding ATER

Bayesian Capital Management's ATER Position: Q2 2023 in Review

Bayesian Capital Management sold out of Aterian (ATER) in Q2 2023, closing a stake of 2,033 shares — an estimated $21K sold.

Bayesian Capital Management first reported a position in ATER in Q4 2021 and held it in 4 quarters. The position peaked at $250K in Q2 2022. 62 funds tracked by Wall St. Rank hold ATER as of Q2 2023.

  • Bayesian Capital Management reported no remaining Aterian position as of Q2 2023 after selling out during the quarter.
  • Bayesian Capital Management sold 2,033 Aterian shares in Q2 2023, an estimated $21K.
  • Bayesian Capital Management first reported a position in Aterian in Q4 2021 and held it in 4 quarters.
  • Bayesian Capital Management's Aterian position peaked at $250K in Q2 2022.
  • 62 funds tracked by Wall St. Rank held Aterian as of Q2 2023.

Based on Bayesian Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.